Search Results for 'Her2-Peg'

Her2-Peg published presentations and documents on DocSlides.

Her2 + Breast Cancer Laura

Her2 + Breast Cancer Laura

by ximena

Bidstrup. Mrs B is a 49 . yo. woman who attended ...

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

by arya

Luminal B-like (HER2-positive):!ER-positive!HER2-p...

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

by carny

Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...

Module 9: HER2-Positive and

Module 9: HER2-Positive and

by norah

Triple-Negative Breast Cancer. Jamie Carroll, APRN...

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

by marina-yarberry

Management of HER2 Over-Expressed Breast Cancer i...

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

by danika-pritchard

ASCO-CAP Recommendations For HER2 Testing in Brea...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

by danika-pritchard

Clinical Practice Guideline Update. American Soci...

Metastatic HER2-Positive Breast Cancer: Treatment Selection

Metastatic HER2-Positive Breast Cancer: Treatment Selection

by test

First . Line and Beyond. Moderator:. Joseph Gligo...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

by danika-pritchard

Clinical Practice Guideline Update. American Soci...

Metastatic triple-positive

Metastatic triple-positive

by marcos147

breast. . cancer. . needs. . different. . ther...

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

by delcy

Trastuzumab-emtansine. : A . very. . nice. . poi...

Module 9: HER2-Positive and Triple-Negative BC

Module 9: HER2-Positive and Triple-Negative BC

by unita

Percent with Patients. Number of Patients (Median)...

2020 Year in Review: Breast Cancer

2020 Year in Review: Breast Cancer

by caroline

Lisa A. Carey MD, . ScM. University of North Carol...

Changes in Breast Cancer Reports After Second Opinion

Changes in Breast Cancer Reports After Second Opinion

by unita

Dr. Vicente Marco. Department of Pathology. Hospit...

CA BREAST D r S ana

CA BREAST D r S ana

by oconnor

ishtiaq. . FCPS R3 general surgery unit one UKSO...

Denise A. Yardley, MD Sarah Cannon Research Institute

Denise A. Yardley, MD Sarah Cannon Research Institute

by lily

Senior Investigator, . Breast Cancer Research. Ten...

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

by gelbero

Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...

Antibody–Drug Conjugates

Antibody–Drug Conjugates

by wang

in Development for . Breast Cancer. Sara A. Hurvit...

Antibody–Drug Conjugates in Development for Non-

Antibody–Drug Conjugates in Development for Non-

by elizabeth

s. mall Cell . Lung Cancer. , Gastric Cancer, and ...

Central Asian Journal of

Central Asian Journal of

by cady

15 Medical and Pharmaceutical Sciences Innovation ...

ORIGINALARTICLEBREASTONCOLOGY

ORIGINALARTICLEBREASTONCOLOGY

by emery

SentinelLymphNodeBiopsyAfterNeoadjuvantChemotherap...

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

by Kingslayer

A. University of Tennessee Medical Center – Knox...

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

by katrgolden

Contents PageIntended Use 4Summary and Explanation...

Product Pipeline Neratinib

Product Pipeline Neratinib

by coursion

across the breast cancer therapy spectrum. Phase I...

Endocrine resistance: molecular pathways and rational development of targeted therapies

Endocrine resistance: molecular pathways and rational development of targeted therapies

by spottletoefacebook

Grazia Arpino. Università di Napoli Federico II. ...

Updates in the Treatment of Breast cancer

Updates in the Treatment of Breast cancer

by alexa-scheidler

Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...

Metastatic Breast Cancer: A Medical Update

Metastatic Breast Cancer: A Medical Update

by liane-varnes

Jennifer M. Matro, MD. Rena Rowan Breast Center. ...

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

by debby-jeon

Monica Brown, MPH, PhD. . California Cancer Regi...

ID DB06366 CATEGORY

ID DB06366 CATEGORY

by luanne-stotts

Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...

by tawny-fly

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

What’s new in Anatomic Pathology Quality Assurance?

What’s new in Anatomic Pathology Quality Assurance?

by alida-meadow

. Raouf E. Nakhleh, MD. Mayo Clinic Florida. Dis...

United States Studies

United States Studies

by leighton789

Colorectal, Renal, Germ Cell, Lung, Neuroendocrine...

Systemic Therapy of Breast Cancer

Systemic Therapy of Breast Cancer

by abigail

Jo Anne Zujewski, M.D.. June 2019. Thimphu. , Bhut...

GIULIANA D’AURIA UOC Oncologia ASL Roma 2

GIULIANA D’AURIA UOC Oncologia ASL Roma 2

by hadley

Osp. . Pertini-S.Eugenio-CTO. Therapeutic. . app...

Istituto Toscano Tumori –Livorno, Italy

Istituto Toscano Tumori –Livorno, Italy

by payton

Federico . Cappuzzo. Istituto Toscano Tumori. Ospe...

Supplementary Figure 1 Supplementary Figure 1: Consort flow chart.

Supplementary Figure 1 Supplementary Figure 1: Consort flow chart.

by leah

Consort flow chart summarizing the number of patie...

Module 8: ER-Positive Metastatic

Module 8: ER-Positive Metastatic

by anastasia

Breast Cancer . Elizabeth O’Reilly, MSN, MPH, AN...

Predictive marker update &

Predictive marker update &

by ella

multiparameter. molecular markers. September 25, ...

Cutoff value for prominent biomarkers of breast cancer on overall survival using CART analysis

Cutoff value for prominent biomarkers of breast cancer on overall survival using CART analysis

by eddey

Pragya Kumari. 1. , . Atanu. Bhattacharjee. 2. , ...

SWAG guidelines Mark Beresford

SWAG guidelines Mark Beresford

by natalie

Oncotype. DX testing in network. Node negative �...